Pharmacokinetics of Haloperidol in Critically Ill Patients: Is There an Association with Inflammation?
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14030549
Abstract: Haloperidol is considered the first-line treatment for delirium in critically ill patients. However, clinical evidence of efficacy is lacking and no pharmacokinetic studies have been performed in intensive care unit (ICU) patients. The aim of… read more here.
Keywords: ill patients; inflammation; haloperidol critically; critically ill ... See more keywords